In October 2016, as a result of audit carried out by Lebanese Ministry of Health (MOH) at PHARMAPRO
Mediphar Labs. has launched DOLFEIN® tablet in March 2018 in the Lebanese market.
Mediphar Labs. has launched DILO® gel in August 2018 in the Lebanese market.